Overview

Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients

Status:
Completed
Trial end date:
2019-09-25
Target enrollment:
Participant gender:
Summary
Phase I study of multiple-dose Kukoamine B Mesilate in Sepsis Patients
Phase:
Phase 1
Details
Lead Sponsor:
Tianjin Chasesun Pharmaceutical Co., LTD
Collaborator:
Southwest Hospital, China